U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
86413
Substance Class Protein
Created
by admin
on Sat Dec 16 17:03:55 UTC 2023
Edited
by admin
on Sat Dec 16 17:03:55 UTC 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN-MACAQUE CHIMERIC
Sequence Type COMPLETE
Record UNII
S9OX9692ZB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GALIXIMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
Galiximab [WHO-DD]
Common Name English
GALIXIMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD80 (ANTIGEN)) (HUMAN-MACACA IRUS MONOCLONAL IDEC-114 HEAVY CHAIN), DISULFIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-114 .LAMBDA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD80 (ANTIGEN)) (HUMAN-MACACA IRUS MONOCLONAL IDEC-114 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-114 .LAMBDA.-CHAIN, DIMER
Common Name English
galiximab [INN]
Common Name English
IDEC-114
Code English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 17:03:55 UTC 2023 , Edited by admin on Sat Dec 16 17:03:55 UTC 2023
Code System Code Type Description
ChEMBL
CHEMBL2109191
Created by admin on Sat Dec 16 17:03:55 UTC 2023 , Edited by admin on Sat Dec 16 17:03:55 UTC 2023
PRIMARY
NCI_THESAURUS
C26447
Created by admin on Sat Dec 16 17:03:55 UTC 2023 , Edited by admin on Sat Dec 16 17:03:55 UTC 2023
PRIMARY
USAN
OO-29
Created by admin on Sat Dec 16 17:03:55 UTC 2023 , Edited by admin on Sat Dec 16 17:03:55 UTC 2023
PRIMARY
WIKIPEDIA
GALIXIMAB
Created by admin on Sat Dec 16 17:03:55 UTC 2023 , Edited by admin on Sat Dec 16 17:03:55 UTC 2023
PRIMARY
CAS
357613-77-5
Created by admin on Sat Dec 16 17:03:55 UTC 2023 , Edited by admin on Sat Dec 16 17:03:55 UTC 2023
PRIMARY
INN
8339
Created by admin on Sat Dec 16 17:03:55 UTC 2023 , Edited by admin on Sat Dec 16 17:03:55 UTC 2023
PRIMARY
FDA UNII
S9OX9692ZB
Created by admin on Sat Dec 16 17:03:55 UTC 2023 , Edited by admin on Sat Dec 16 17:03:55 UTC 2023
PRIMARY
DRUG BANK
DB04901
Created by admin on Sat Dec 16 17:03:55 UTC 2023 , Edited by admin on Sat Dec 16 17:03:55 UTC 2023
PRIMARY
From To
1_22 1_97
1_154 1_210
1_230 3_215
1_236 2_236
1_239 2_239
1_271 1_331
1_377 1_435
2_22 2_97
2_154 2_210
2_230 4_215
2_271 2_331
2_377 2_435
3_22 3_89
3_138 3_197
4_22 4_89
4_138 4_197
Related Record Type Details
T-LYMPHOCYTE ACTIVATION ANTIGEN CD80
TARGET -> INHIBITOR
Related Record Type Details
GALIXIMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:ESTIMATED CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966